Cargando…

Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition

BACKGROUND: As an acute febrile and inflammatory disease, Kawasaki disease (KD) could develop Kawasaki disease shock syndrome (KDSS) sometimes. However its pathogenesis was still not well known. This study was to learn more about the clinical features and evaluate the role of cytokines in the pathog...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yandie, Zheng, Qi, Zou, Lixia, Wu, Jianqiang, Guo, Li, Teng, Liping, Zheng, Rongjun, Jung, Lawrence Kwok Leung, Lu, Meiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321686/
https://www.ncbi.nlm.nih.gov/pubmed/30611297
http://dx.doi.org/10.1186/s12969-018-0303-4
_version_ 1783385501005250560
author Li, Yandie
Zheng, Qi
Zou, Lixia
Wu, Jianqiang
Guo, Li
Teng, Liping
Zheng, Rongjun
Jung, Lawrence Kwok Leung
Lu, Meiping
author_facet Li, Yandie
Zheng, Qi
Zou, Lixia
Wu, Jianqiang
Guo, Li
Teng, Liping
Zheng, Rongjun
Jung, Lawrence Kwok Leung
Lu, Meiping
author_sort Li, Yandie
collection PubMed
description BACKGROUND: As an acute febrile and inflammatory disease, Kawasaki disease (KD) could develop Kawasaki disease shock syndrome (KDSS) sometimes. However its pathogenesis was still not well known. This study was to learn more about the clinical features and evaluate the role of cytokines in the pathogenesis of KDSS. METHODS: We collected clinical and laboratory data retrospectively for all patients with KDSS(KDSS, n = 27)who were hospitalized at our hospital from Jan 2014 to Oct 2017. For patient with KDSS, we randomly identified 43 patients with KD as control subjects (KD, n = 43). Clinical features, laboratory evaluations were collected. Cytokines IL-2, IL-4, IL-6, IL-10, TNF-α and IFN-γ in serum were assayed using flow cytometric bead array. RESULTS: The patients with KDSS were older age (43.41 ± 31.42 vs 28.81 ± 21.51 months, P < 0.05), longer duration of fever (10.63 ± 5.12 vs 6.98 ± 2.45 days, P < 0.05), higher WBC count, neutrophils, CRP, ESR, PCT and D-dimer, and lower hemoglobin and albumin, more severe hyponatremia and hypokalemia, more refractory to IVIG therapy, more coronary artery abnormalities (CAAs), aseptic meningitis, and longer duration of hospitalization than patients with KD (all P < 0.05). The levels of serum IL-6 [184.1 (27.7–2577.3) vs 54.1 (4–425) pg/ml], IL-10 [42.6 (5–236.7) vs 9.4 (3–94) pg/ml], TNF-α [2.6 (1.0–23.4) vs 2.1 (1–6) pg/ml] and IFN-γ [18.3 (4.5–94.4) vs 6.7 (2–56) pg/ml] in KDSS patients were significant higher than KD patients (all P < 0.05). ROC curves showed that 66.7 pg/ml of IL-6, 20.85 pg/ml of IL-10 and 8.35 pg/ml of IFN-γ had sensitivity and specificity for identifying KDSS as 85.2 and 62.8%; 66.7 and 83.7%; 74.1 and 74.4% respectively. No fatality was recorded in this series. CONCLUSIONS: KDSS were characteristic as more cytokine production and prone to developing IVIG non-responsiveness and CAAs. KD patients with IL-6 above 66.7 pg/ml, IL-10 above 20.85 pg/ml, and IFN-γ above 8.35 pg/ml suggested higher risk for KDSS.
format Online
Article
Text
id pubmed-6321686
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63216862019-01-09 Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition Li, Yandie Zheng, Qi Zou, Lixia Wu, Jianqiang Guo, Li Teng, Liping Zheng, Rongjun Jung, Lawrence Kwok Leung Lu, Meiping Pediatr Rheumatol Online J Research Article BACKGROUND: As an acute febrile and inflammatory disease, Kawasaki disease (KD) could develop Kawasaki disease shock syndrome (KDSS) sometimes. However its pathogenesis was still not well known. This study was to learn more about the clinical features and evaluate the role of cytokines in the pathogenesis of KDSS. METHODS: We collected clinical and laboratory data retrospectively for all patients with KDSS(KDSS, n = 27)who were hospitalized at our hospital from Jan 2014 to Oct 2017. For patient with KDSS, we randomly identified 43 patients with KD as control subjects (KD, n = 43). Clinical features, laboratory evaluations were collected. Cytokines IL-2, IL-4, IL-6, IL-10, TNF-α and IFN-γ in serum were assayed using flow cytometric bead array. RESULTS: The patients with KDSS were older age (43.41 ± 31.42 vs 28.81 ± 21.51 months, P < 0.05), longer duration of fever (10.63 ± 5.12 vs 6.98 ± 2.45 days, P < 0.05), higher WBC count, neutrophils, CRP, ESR, PCT and D-dimer, and lower hemoglobin and albumin, more severe hyponatremia and hypokalemia, more refractory to IVIG therapy, more coronary artery abnormalities (CAAs), aseptic meningitis, and longer duration of hospitalization than patients with KD (all P < 0.05). The levels of serum IL-6 [184.1 (27.7–2577.3) vs 54.1 (4–425) pg/ml], IL-10 [42.6 (5–236.7) vs 9.4 (3–94) pg/ml], TNF-α [2.6 (1.0–23.4) vs 2.1 (1–6) pg/ml] and IFN-γ [18.3 (4.5–94.4) vs 6.7 (2–56) pg/ml] in KDSS patients were significant higher than KD patients (all P < 0.05). ROC curves showed that 66.7 pg/ml of IL-6, 20.85 pg/ml of IL-10 and 8.35 pg/ml of IFN-γ had sensitivity and specificity for identifying KDSS as 85.2 and 62.8%; 66.7 and 83.7%; 74.1 and 74.4% respectively. No fatality was recorded in this series. CONCLUSIONS: KDSS were characteristic as more cytokine production and prone to developing IVIG non-responsiveness and CAAs. KD patients with IL-6 above 66.7 pg/ml, IL-10 above 20.85 pg/ml, and IFN-γ above 8.35 pg/ml suggested higher risk for KDSS. BioMed Central 2019-01-05 /pmc/articles/PMC6321686/ /pubmed/30611297 http://dx.doi.org/10.1186/s12969-018-0303-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Li, Yandie
Zheng, Qi
Zou, Lixia
Wu, Jianqiang
Guo, Li
Teng, Liping
Zheng, Rongjun
Jung, Lawrence Kwok Leung
Lu, Meiping
Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition
title Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition
title_full Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition
title_fullStr Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition
title_full_unstemmed Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition
title_short Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition
title_sort kawasaki disease shock syndrome: clinical characteristics and possible use of il-6, il-10 and ifn-γ as biomarkers for early recognition
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321686/
https://www.ncbi.nlm.nih.gov/pubmed/30611297
http://dx.doi.org/10.1186/s12969-018-0303-4
work_keys_str_mv AT liyandie kawasakidiseaseshocksyndromeclinicalcharacteristicsandpossibleuseofil6il10andifngasbiomarkersforearlyrecognition
AT zhengqi kawasakidiseaseshocksyndromeclinicalcharacteristicsandpossibleuseofil6il10andifngasbiomarkersforearlyrecognition
AT zoulixia kawasakidiseaseshocksyndromeclinicalcharacteristicsandpossibleuseofil6il10andifngasbiomarkersforearlyrecognition
AT wujianqiang kawasakidiseaseshocksyndromeclinicalcharacteristicsandpossibleuseofil6il10andifngasbiomarkersforearlyrecognition
AT guoli kawasakidiseaseshocksyndromeclinicalcharacteristicsandpossibleuseofil6il10andifngasbiomarkersforearlyrecognition
AT tengliping kawasakidiseaseshocksyndromeclinicalcharacteristicsandpossibleuseofil6il10andifngasbiomarkersforearlyrecognition
AT zhengrongjun kawasakidiseaseshocksyndromeclinicalcharacteristicsandpossibleuseofil6il10andifngasbiomarkersforearlyrecognition
AT junglawrencekwokleung kawasakidiseaseshocksyndromeclinicalcharacteristicsandpossibleuseofil6il10andifngasbiomarkersforearlyrecognition
AT lumeiping kawasakidiseaseshocksyndromeclinicalcharacteristicsandpossibleuseofil6il10andifngasbiomarkersforearlyrecognition